Clinical TrialsSearch results
Number of results: 237
Other
- Chronic Heart Failure Analysis and Registry in the Tohoku District 2
- Chronic heart failure Patients with high risk for heart failure
- Tohoku Heart Failure Association The CHART-2 Study Group
- 2006-12-26
Other
- Supplemental Benefit of Angiotensin II Receptor Blocker in Hypertensive Patients with Stable Heart Failure using Olmesartan
- Chronic Heart Failure
- Tohoku Heart Failure Association The SUPPORT Study Group
- 2006-12-26
Recruiting
- Effects of rabeprazole on acute exacerbation in chronic obstructive pulmonary disease (COPD) patients with acid reflux symptoms
- chronic obstructive pulmonary disease (COPD), gastroesophageal reflux disease
- Tohoku University Graduate School of Medicine
- 2009-06-10
Other
- Phase II study of amrubicin combined with carboplatin for refractory relapsed small-cell lung cancer
- Small-cell lung cancer
- Tohoku University Hospital
- 2010-03-31
Other
- Phase II study of amrubicin combined with carboplatin for unresectable invasive thymoma or thymic carcinoma
- Thymoma/Thymic carcinoma
- Tohoku University Hospital
- 2010-03-31
Other
- Randomized Phase II Trial Comparing Docetaxel with weekly Paclitaxel and Carboplatin in Elderly Patients with Non-Small Cell Lung Cancer
- Non-small cell lung cancer
- Tohoku University Hospital
- 2010-03-31
Other
- Randomized PhaseII study of amrubicin vs platinum-doublet re-challenge for small cell lung cancer with sensitive relapse
- Small-Cell Lung Cancer
- Tohoku University Hospital
- 2010-03-31
Other
- Liver resection after chemotherapy for liver only metastasis from colorectal cancer
- Liver metastasis of colorectal cancer
- Tokyo Medical & Dental University
- 2009-06-22
Other
- Biomarker-Cohort Study of Adjuvant Chemotherapy for Stage III Colon Cancer
- Colon cancer
- Tokyo Medical and Dental University
- 2009-05-29
Other
- Multi-institute randomized study of natural type interferon alpha for patients with renal cell carcinoma after radical nephrectomy
- Renal cell carcinoma
- TRAIn-Alpha study group
- 2005-09-30